SynBioBeta Speaker

Shelby Newsad

Investor

Compound.vc

YEAR

25

May 2025, SynBioBeta

Speaker

Shelby is an investor at Compound with a focus on Biology and Healthcare. Shelby is an undergraduate in Biochemistry with an engineering minor, an MPhil in Bioscience Enterprise and a PhD in Plant Sciences from University of Cambridge (currently awaiting her oral defense). Her research experience spans neuroscience (Serpe Lab, National Institutes of Health, Bethesda, Maryland), drug discovery (Titz Lab, Helmholtz Institute, Saarbrücken, Germany) and her recent PhD project in microalgae symbioses in the Plant Sciences Department (Smith Lab, University of Cambridge, UK). Through her interest in science translation, she has interned with Merck KGaA at the Innovation Center in Germany and worked with European VC funds, such as Hummingbird Ventures, Ahren Innovation Capital, and Start Codon.

SynBioBeta 2025 - Keynote

Bio/acc and Biohack: The Science Behind the Hype

Bio/acc and Biohacking have both become popular movements on Twitter of late. This session brings together people who 'hype' them up and people who temper these sectors with science and point out flawed approaches. Get ready for a spicy conversation.

SynBioBeta 2026 Tickets are Live

Confirmed Speakers

VIP Pass

9,995

USD

Conference Pass +

VIP Dinner

VIP Reception

Concierge Intros

Conference Content

Purchase Pass

Purchase Pass

Free cancelation through 2 weeks before the event, if you book before October 31st.

VIP Pass

9,995

USD

Conference Pass +

VIP Dinner

VIP Reception

Concierge Intros

Conference Content

Purchase Pass

Purchase Pass

Free cancelation through 2 weeks before the event, if you book before October 31st.

VIP Pass

9,995

USD

Conference Pass +

VIP Dinner

VIP Reception

Concierge Intros

Conference Content

Purchase Pass

Purchase Pass

Free cancelation through 2 weeks before the event, if you book before October 31st.

Previous Speakers Include

Sign Up
Sign Up